<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>禾新生醫股份有限公司 Helixism Biomedical Inc.</title>
	<atom:link href="https://helixism.com/en/feed/" rel="self" type="application/rss+xml" />
	<link>https://helixism.com/en/home/</link>
	<description></description>
	<lastBuildDate>Wed, 07 Aug 2024 01:55:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title>HECP-1000 Officially Receives Taiwan FDA</title>
		<link>https://helixism.com/en/hecp-1000-officially-receives-taiwan-fda/</link>
		
		<dc:creator><![CDATA[info.tw]]></dc:creator>
		<pubDate>Wed, 07 Aug 2024 01:25:17 +0000</pubDate>
				<category><![CDATA[LATEST NEWS]]></category>
		<guid isPermaLink="false">https://helixism.com/?p=5469</guid>

					<description><![CDATA[<p>We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products. &#160; The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions [&#8230;]</p>
<p>這篇文章 <a rel="nofollow" href="https://helixism.com/en/hecp-1000-officially-receives-taiwan-fda/">HECP-1000 Officially Receives Taiwan FDA</a> 最早出現於 <a rel="nofollow" href="https://helixism.com/en/">禾新生醫股份有限公司 Helixism Biomedical Inc.</a>。</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>HBI team has achieved QMS certification and securing a U.S. patent</title>
		<link>https://helixism.com/en/hbi-team-has-achieved-qms-certification-and-securing-a-u-s-patent/</link>
		
		<dc:creator><![CDATA[info.tw]]></dc:creator>
		<pubDate>Thu, 14 Dec 2023 02:43:51 +0000</pubDate>
				<category><![CDATA[LATEST NEWS]]></category>
		<guid isPermaLink="false">https://helixism.com/?p=5382</guid>

					<description><![CDATA[<p>We are thrilled to share that HBI has achieved a significant milestone by receiving Quality Management System (QMS) certification and securing a U.S. patent. Each member of our team has contributed their exceptional dedication and expertise to this achievement. As we continue to receive a growing volume of both positive and insightful feedback directly from [&#8230;]</p>
<p>這篇文章 <a rel="nofollow" href="https://helixism.com/en/hbi-team-has-achieved-qms-certification-and-securing-a-u-s-patent/">HBI team has achieved QMS certification and securing a U.S. patent</a> 最早出現於 <a rel="nofollow" href="https://helixism.com/en/">禾新生醫股份有限公司 Helixism Biomedical Inc.</a>。</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Connecting with the Executive Director of the Taiwan ST Hub at Stanford University</title>
		<link>https://helixism.com/en/%e8%88%87%e5%8f%b2%e4%b8%b9%e4%bd%9b%e5%a4%a7%e5%ad%b8%e5%8f%b0%e7%81%a3%e7%a7%91%e6%8a%80%e4%b8%ad%e5%bf%83%e4%b8%bb%e4%bb%bb%ef%bc%8c%e5%b1%95%e6%9c%9b%e6%9c%aa%e4%be%86%e7%9a%84%e5%90%88%e4%bd%9c/</link>
		
		<dc:creator><![CDATA[supervisor01]]></dc:creator>
		<pubDate>Fri, 01 Sep 2023 06:00:01 +0000</pubDate>
				<category><![CDATA[LATEST NEWS]]></category>
		<guid isPermaLink="false">https://helixism.com/%e8%88%87%e5%8f%b2%e4%b8%b9%e4%bd%9b%e5%a4%a7%e5%ad%b8%e5%8f%b0%e7%81%a3%e7%a7%91%e6%8a%80%e4%b8%ad%e5%bf%83%e4%b8%bb%e4%bb%bb%ef%bc%8c%e5%b1%95%e6%9c%9b%e6%9c%aa%e4%be%86%e7%9a%84%e5%90%88%e4%bd%9c/</guid>

					<description><![CDATA[<p>During a recent event in Kaohsiung City, a representative from Helixism Biomedical Inc. (HBI) had the opportunity to engage with Dr. Laura Smoliar, Executive Director of the Taiwan Science and Technology Hub at Stanford University. The conversation proved invaluable as Dr. Smoliar provided strategic advice and introduced HBI to several Bay Area programs focused on [&#8230;]</p>
<p>這篇文章 <a rel="nofollow" href="https://helixism.com/en/%e8%88%87%e5%8f%b2%e4%b8%b9%e4%bd%9b%e5%a4%a7%e5%ad%b8%e5%8f%b0%e7%81%a3%e7%a7%91%e6%8a%80%e4%b8%ad%e5%bf%83%e4%b8%bb%e4%bb%bb%ef%bc%8c%e5%b1%95%e6%9c%9b%e6%9c%aa%e4%be%86%e7%9a%84%e5%90%88%e4%bd%9c/">Connecting with the Executive Director of the Taiwan ST Hub at Stanford University</a> 最早出現於 <a rel="nofollow" href="https://helixism.com/en/">禾新生醫股份有限公司 Helixism Biomedical Inc.</a>。</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Latest healthcare investment trend by Silicon Valley Bank in Seattle</title>
		<link>https://helixism.com/en/%e8%a5%bf%e9%9b%85%e5%9c%96-svb-%e6%9c%80%e6%96%b0%e7%9a%84%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e6%8a%95%e8%b3%87%e8%b6%a8%e5%8b%a2%ef%bc%8c%e4%bc%81%e6%a5%ad%e4%bb%a3%e8%a1%a8%e4%ba%92%e7%9b%b8/</link>
		
		<dc:creator><![CDATA[supervisor01]]></dc:creator>
		<pubDate>Tue, 15 Aug 2023 06:00:40 +0000</pubDate>
				<category><![CDATA[LATEST NEWS]]></category>
		<guid isPermaLink="false">https://helixism.com/%e8%a5%bf%e9%9b%85%e5%9c%96-svb-%e6%9c%80%e6%96%b0%e7%9a%84%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e6%8a%95%e8%b3%87%e8%b6%a8%e5%8b%a2%ef%bc%8c%e4%bc%81%e6%a5%ad%e4%bb%a3%e8%a1%a8%e4%ba%92%e7%9b%b8/</guid>

					<description><![CDATA[<p>Following a recent trip to Seattle, a representative from Helixism Biomedical Inc. (HBI) attended an array of engaging venture capital events. Insights into healthcare investment trends were provided by Silicon Valley Bank (SVB), who also offered invaluable strategic advice and facilitated key introductions. Institutions like the University of Washington and 360 Social Venture showcased notable [&#8230;]</p>
<p>這篇文章 <a rel="nofollow" href="https://helixism.com/en/%e8%a5%bf%e9%9b%85%e5%9c%96-svb-%e6%9c%80%e6%96%b0%e7%9a%84%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e6%8a%95%e8%b3%87%e8%b6%a8%e5%8b%a2%ef%bc%8c%e4%bc%81%e6%a5%ad%e4%bb%a3%e8%a1%a8%e4%ba%92%e7%9b%b8/">Latest healthcare investment trend by Silicon Valley Bank in Seattle</a> 最早出現於 <a rel="nofollow" href="https://helixism.com/en/">禾新生醫股份有限公司 Helixism Biomedical Inc.</a>。</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Groundwork for U.S. Expansion: Establishing U.S. Connections in San Francisco and Stanford</title>
		<link>https://helixism.com/en/groundwork-for-u-s-expansion-establishing-u-s-connections-in-san-francisco-and-stanford/</link>
		
		<dc:creator><![CDATA[info.tw]]></dc:creator>
		<pubDate>Sun, 30 Jul 2023 06:00:07 +0000</pubDate>
				<category><![CDATA[LATEST NEWS]]></category>
		<guid isPermaLink="false">https://helixism.com/?p=5261</guid>

					<description><![CDATA[<p>During a recent business visit to San Francisco and Stanford University, a representative from Helixism Biomedical Inc. (HBI) engaged with a select group of accomplished entrepreneurs, investors, and delegates from visionary corporations. The primary focus of this pivotal trip was to establish connections and network for future collaborations, as part of HBI&#8217;s strategic preparation for [&#8230;]</p>
<p>這篇文章 <a rel="nofollow" href="https://helixism.com/en/groundwork-for-u-s-expansion-establishing-u-s-connections-in-san-francisco-and-stanford/">Groundwork for U.S. Expansion: Establishing U.S. Connections in San Francisco and Stanford</a> 最早出現於 <a rel="nofollow" href="https://helixism.com/en/">禾新生醫股份有限公司 Helixism Biomedical Inc.</a>。</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
